Other

Swiss pharma Novartis ups full-year sales outlook (Update)

Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...

Health

Managers' religious affiliation impacts hospital strategy

Protestant non-profit hospitals in Germany offer fewer treatment types, but focus more on complex treatments. By contrast, Catholic German hospitals offer more treatment types but focus on less complex treatments. This is ...

Other

German drug maker Merck ups forecast for 2013

German chemicals and pharmaceuticals giant Merck KGaA said Thursday it is raising its full-year operating profit forecast thanks to improving sales and positive cost-cutting effects.

Health

Nonprofit hospitals earn substantial profits

Seven of the 10 most profitable hospitals in the United States in 2013 - each earning more than $163 million in profits from patient care services—were nonprofit hospitals, according to new research from the Johns Hopkins ...

Vaccination

AstraZeneca says Covid vaccine sales top $1.0 bn

British pharmaceuticals giant AstraZeneca said Thursday that its COVID jab generated $1.2 billion (1.0 billion euros) in sales in the first half of the year as global vaccination programmes accelerated.

Other

Novartis Q4 net profit rebounds to $2.1 billion

(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.

page 8 from 11